|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
A-A-30025
|
6505-01-023-3319
|
Hemorrhoidal Suppositories |
Federal Commercial Item Description
|
|
Quote
|
|
ANUSOL
|
6505-01-023-3319
|
Hemorrhoidal Suppositories |
Parke-davis
|
|
Quote
|
|
NDC00713-0121-12
|
6505-01-023-3319
|
Hemorrhoidal Suppositories |
G & W Laboratories, Inc.
|
|
Quote
|
|
NDC00071-1088-07
|
6505-01-023-3319
|
Hemorrhoidal Suppositories |
Parke-davis
|
|
Quote
|
|
NDC00182-0742-11
|
6505-01-023-3319
|
Hemorrhoidal Suppositories |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC45802-0434-01
|
6505-01-023-5011
|
Usp Clotrimazole Cream |
Perrigo Company
|
|
Quote
|
|
NDC45802-0434-01
|
6505-01-023-5011
|
Usp Clotrimazole Cream |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC51672-1275-01
|
6505-01-023-5011
|
Usp Clotrimazole Cream |
Taro Pharmaceuticals Usa Inc
|
|
Quote
|
|
NDC00182-5095-33
|
6505-01-023-5011
|
Usp Clotrimazole Cream |
Ivax Corp
|
|
Quote
|
|
ISOPTO TEARS
|
6505-01-023-5074
|
Hydroxypropyl Methylcellulose Op |
Alcon Canada Inc
|
|
Quote
|
|
408
|
6505-01-023-5074
|
Hydroxypropyl Methylcellulose Op |
Alcon Canada Inc
|
|
Quote
|
|
62-1332-51
|
6505-01-023-5240
|
Norethindrone And Mestranol Tabl |
Ortho Pharmaceutical Corp
|
|
Quote
|
|
R1001
|
6505-01-023-5241
|
Usp Sterile Water For Irrigation |
B Braun Medical Inc
|
|
Quote
|
|
R1201
|
6505-01-023-5242
|
Usp Sodium Chloride Irrigation |
B Braun Medical Inc
|
|
Quote
|
|
25-901-437
|
6505-01-023-5243
|
Norethindrone Acetate And Ethiny |
Parke-davis
|
|
Quote
|
|
1002-01
|
6505-01-023-5244
|
Isoetharine Hydrochloride And Ph |
Gutz Logistics Inc
|
|
Quote
|
|
NDC00467-0187-25
|
6505-01-023-6749
|
Modifi Sodium Chloride Injection |
Invenex Laboratories
|
|
Quote
|
|
187100
|
6505-01-023-6749
|
Modifi Sodium Chloride Injection |
Invenex Laboratories
|
|
Quote
|
|
187100
|
6505-01-023-6749
|
Modifi Sodium Chloride Injection |
Invenex Laboratories
|
|
Quote
|
|
NDC00467-0187-25
|
6505-01-023-6749
|
Modifi Sodium Chloride Injection |
Invenex Laboratories
|
|
Quote
|
|
BLEPH-10 LIQUIFILM
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Allergan Inc
|
|
Quote
|
|
AK-SULF
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Akorn Inc
|
|
Quote
|
|
SULAMYD
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Schering Laboratories
|
|
Quote
|
|
NDC17478-0221-12
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Akorn Inc
|
|
Quote
|
|
70650
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-0671-64
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC24208-0670-04
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC00904-2728-35
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC11980-0011-15
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Allergan Inc
|
|
Quote
|
|
NDC61314-0701-01
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
NDC00998-0522-15
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Alcon Laboratories, Inc.
|
|
Quote
|
|
ISOPTO CETAMIDE
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00085-0946-06
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Schering Laboratories
|
|
Quote
|
|
NDC00998-0522-15
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Alcon Laboratories, Inc.
|
|
Quote
|
|
BLEPH-10 LIQUIFILM
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Allergan Inc
|
|
Quote
|
|
AK-SULF
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Akorn Inc
|
|
Quote
|
|
SULAMYD
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Schering Laboratories
|
|
Quote
|
|
70650
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-0671-64
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC61314-0701-01
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
NDC11980-0011-15
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Allergan Inc
|
|
Quote
|
|
NDC00904-2728-35
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC17478-0221-12
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Akorn Inc
|
|
Quote
|
|
NDC00085-0946-06
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Schering Laboratories
|
|
Quote
|
|
ISOPTO CETAMIDE
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00998-0522-15
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Alcon Laboratories, Inc.
|
|
Quote
|
|
BLEPH-10 LIQUIFILM
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Allergan Inc
|
|
Quote
|
|
AK-SULF
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Akorn Inc
|
|
Quote
|
|
SULAMYD
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Schering Laboratories
|
|
Quote
|
|
70650
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-0671-64
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00904-2728-35
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC11980-0011-15
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Allergan Inc
|
|
Quote
|
|
NDC61314-0701-01
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
NDC17478-0221-12
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Akorn Inc
|
|
Quote
|
|
NDC00085-0946-06
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Schering Laboratories
|
|
Quote
|
|
ISOPTO CETAMIDE
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00998-0522-15
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC24208-0670-04
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Valeant Pharmaceuticals
|
|
Quote
|
|
VELOSEF 500 CAPSULES
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Bristol-myers Co
|
|
Quote
|
|
NDC00781-2534-01
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Sandoz Inc.
|
|
Quote
|
|
NDC00555-0551-02
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Barr Laboratories, Inc.
|
|
Quote
|
|
NDC00332-3155-09
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Biocraft Laboratories Inc
|
|
Quote
|
|
NDC00182-1254-01
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00182-1254-01
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Bristol-myers Co
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Squibb E R and Sons Inc
|
|
Quote
|
|
VELOSEF 500 CAPSULES
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00781-2534-01
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Sandoz Inc.
|
|
Quote
|
|
NDC00555-0551-02
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Barr Laboratories, Inc.
|
|
Quote
|
|
NDC00332-3155-09
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Biocraft Laboratories Inc
|
|
Quote
|
|
NDC00182-1254-01
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Bristol-myers Co
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Squibb E R and Sons Inc
|
|
Quote
|
|
VELOSEF 500 CAPSULES
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00781-2534-01
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Sandoz Inc.
|
|
Quote
|
|
NDC00182-1254-01
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00555-0551-02
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Barr Laboratories, Inc.
|
|
Quote
|
|
NDC00332-3155-09
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Biocraft Laboratories Inc
|
|
Quote
|
|
TALWIN
|
6505-01-024-2626
|
Us Pentazocine Lactate Injection |
Sterling-winthrop Research Institute
|
|
Quote
|
|
NDC00074-1941-01
|
6505-01-024-2626
|
Us Pentazocine Lactate Injection |
Abbott Laboratories
|
|
Quote
|
|
BENDECTIN62476
|
6505-01-024-2653
|
Doxylamine Succinate And Pyridox |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
B5613-18
|
6505-01-024-6430
|
Albumin Clinicard Kit |
Baxter Healthcare Corp
|
|
Quote
|
|
A.S.A. ENSEALS
|
6505-01-024-6462
|
Usp Aspirin Tablets |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-0132-04
|
6505-01-024-6462
|
Usp Aspirin Tablets |
Eli Lilly and Company
|
|
Quote
|
|
ETRAFON-2-10
|
6505-01-024-6464
|
Perphenazine And Amitriptyline H |
Schering Corp
|
|
Quote
|
|
NDC085-0287-07
|
6505-01-024-6464
|
Perphenazine And Amitriptyline H |
Schering Corp
|
|
Quote
|
|
LASIX
|
6505-01-024-9304
|
Usp Furosemide Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
NDC00039-0067-50
|
6505-01-024-9304
|
Usp Furosemide Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
NDC00536-3840-05
|
6505-01-024-9304
|
Usp Furosemide Tablets |
Rugby Group Inc
|
|
Quote
|
|
NDC00039-0067-50
|
6505-01-024-9304
|
Usp Furosemide Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
LASIX
|
6505-01-024-9304
|
Usp Furosemide Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
NDC00536-3840-05
|
6505-01-024-9304
|
Usp Furosemide Tablets |
Rugby Group Inc
|
|
Quote
|
|
NDC00039-0067-50
|
6505-01-024-9304
|
Usp Furosemide Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
LASIX
|
6505-01-024-9304
|
Usp Furosemide Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
NDC00536-3840-05
|
6505-01-024-9304
|
Usp Furosemide Tablets |
Rugby Group Inc
|
|
Quote
|
|
NDC00039-0067-50
|
6505-01-024-9304
|
Usp Furosemide Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
LASIX
|
6505-01-024-9304
|
Usp Furosemide Tablets |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
NDC00536-3840-05
|
6505-01-024-9304
|
Usp Furosemide Tablets |
Rugby Group Inc
|
|
Quote
|
|
PAREPECTOLIN
|
6505-01-024-9333
|
And Pectin Susp Kaolin Paregoric |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00067-0660-60
|
6505-01-024-9333
|
And Pectin Susp Kaolin Paregoric |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
PAREPECTOLIN
|
6505-01-024-9333
|
And Pectin Susp Kaolin Paregoric |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00067-0660-60
|
6505-01-024-9333
|
And Pectin Susp Kaolin Paregoric |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
PAREPECTOLIN
|
6505-01-024-9333
|
And Pectin Susp Kaolin Paregoric |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00067-0660-60
|
6505-01-024-9333
|
And Pectin Susp Kaolin Paregoric |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
PAREPECTOLIN
|
6505-01-024-9333
|
And Pectin Susp Kaolin Paregoric |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00067-0660-60
|
6505-01-024-9333
|
And Pectin Susp Kaolin Paregoric |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
PAREPECTOLIN
|
6505-01-024-9333
|
And Pectin Susp Kaolin Paregoric |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00067-0660-60
|
6505-01-024-9333
|
And Pectin Susp Kaolin Paregoric |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
PAREPECTOLIN
|
6505-01-024-9333
|
And Pectin Susp Kaolin Paregoric |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00067-0660-60
|
6505-01-024-9333
|
And Pectin Susp Kaolin Paregoric |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
AEROZOIN
|
6505-01-024-9334
|
Usp Compound Benzoin Tincture |
Aeroceuticals Div of Ati Inc
|
|
Quote
|
|
NDC00534-0103-06
|
6505-01-024-9334
|
Usp Compound Benzoin Tincture |
Aeroceuticals Div of Ati Inc
|
|
Quote
|
|
AEROZOIN
|
6505-01-024-9334
|
Usp Compound Benzoin Tincture |
Aeroceuticals Div of Ati Inc
|
|
Quote
|
|
NDC00534-0103-06
|
6505-01-024-9334
|
Usp Compound Benzoin Tincture |
Aeroceuticals Div of Ati Inc
|
|
Quote
|
|
AEROZOIN
|
6505-01-024-9334
|
Usp Compound Benzoin Tincture |
Aeroceuticals Div of Ati Inc
|
|
Quote
|
|
NDC00534-0103-06
|
6505-01-024-9334
|
Usp Compound Benzoin Tincture |
Aeroceuticals Div of Ati Inc
|
|
Quote
|
|
AEROZOIN
|
6505-01-024-9334
|
Usp Compound Benzoin Tincture |
Aeroceuticals Div of Ati Inc
|
|
Quote
|
|
NDC00534-0103-06
|
6505-01-024-9334
|
Usp Compound Benzoin Tincture |
Aeroceuticals Div of Ati Inc
|
|
Quote
|
|
AEROZOIN
|
6505-01-024-9334
|
Usp Compound Benzoin Tincture |
Aeroceuticals Div of Ati Inc
|
|
Quote
|
|
NDC00534-0103-06
|
6505-01-024-9334
|
Usp Compound Benzoin Tincture |
Aeroceuticals Div of Ati Inc
|
|
Quote
|
|
AEROZOIN
|
6505-01-024-9334
|
Usp Compound Benzoin Tincture |
Aeroceuticals Div of Ati Inc
|
|
Quote
|
|
NDC00534-0103-06
|
6505-01-024-9334
|
Usp Compound Benzoin Tincture |
Aeroceuticals Div of Ati Inc
|
|
Quote
|
|
CATAPRES
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
CATAPRES TABLETS
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
NDC00597-0007-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
NDC00005-3181-34
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
American Cyanamid Co
|
|
Quote
|
|
NDC00781-1472-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Sandoz Inc.
|
|
Quote
|
|
NDC00378-0186-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC00378-0186-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
CATAPRES
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
CATAPRES TABLETS
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
NDC00597-0007-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
NDC00378-0186-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC00781-1472-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Sandoz Inc.
|
|
Quote
|
|
NDC00378-0186-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00005-3181-34
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
American Cyanamid Co
|
|
Quote
|
|
CATAPRES
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
CATAPRES TABLETS
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
NDC00597-0007-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
NDC00781-1472-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Sandoz Inc.
|
|
Quote
|
|
NDC00378-0186-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC00378-0186-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00005-3181-34
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
American Cyanamid Co
|
|
Quote
|
|
CATAPRES
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
CATAPRES TABLETS
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
NDC00597-0007-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
NDC00378-0186-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC00781-1472-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Sandoz Inc.
|
|
Quote
|
|
NDC00378-0186-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00005-3181-34
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
American Cyanamid Co
|
|
Quote
|
|
CATAPRES
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
CATAPRES TABLETS
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
NDC00597-0007-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Boehringer Ingelheim
|
|
Quote
|
|
NDC00378-0186-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC00781-1472-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Sandoz Inc.
|
|
Quote
|
|
NDC00378-0186-10
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00005-3181-34
|
6505-01-024-9879
|
Clonidine Hydrochloride Tablets |
American Cyanamid Co
|
|
Quote
|
|
NDC54-8712-00
|
6505-01-025-4637
|
Potassium Chloride Oral Solution |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC54-8712-00
|
6505-01-025-4637
|
Potassium Chloride Oral Solution |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
75525
|
6505-01-025-8575
|
Chlordiazepoxide Hydrochloride A |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00140-0007-52
|
6505-01-025-8575
|
Chlordiazepoxide Hydrochloride A |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00879-0501-09
|
6505-01-025-8575
|
Chlordiazepoxide Hydrochloride A |
Halsey Drug Co Inc
|
|
Quote
|
|
NDC00140-0007-51
|
6505-01-025-8576
|
Chlordiazepoxide Hydrochloride A |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00879-0501-23
|
6505-01-025-8576
|
Chlordiazepoxide Hydrochloride A |
Halsey Drug Co Inc
|
|
Quote
|
|
NDC00140-0003-52
|
6505-01-025-8582
|
Chlordiazepoxide Hydrochloride C |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
76822
|
6505-01-025-8582
|
Chlordiazepoxide Hydrochloride C |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
LIBRIUM
|
6505-01-025-8582
|
Chlordiazepoxide Hydrochloride C |
Hoffmann-la Roche Inc.
|
|
Quote
|
